Raymond James lowered the firm’s price target on ICU Medical (ICUI) to $180 from $187 and keeps a Strong Buy rating on the shares. The Q2 beat gives the firm confidence that underlying business momentum is improving, and this trend should to continue with various new product launches and ongoing efforts to optimize the cost structure, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICUI: